drugset / Trial / NCT01231490

Acute Osteoarthritis Experimental Model Study.

NCT01231490

Phase 2 Completed 53 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blind

Summary

This is a methodological study designed to investigate a new model for testing pain agents in the treatment of patients with osteoarthritis (OA). This will be a double-blind, randomised, placebo controlled three-way cross-over study in patients with OA of the knee.

Timeline

Start
2008-09
Primary completion
2009-01
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Naproxen Small molecule 500 mg

Indications